ORIGINAL ARTICLE

Follow up of a randomised trial of two different courses of dexamethasone for preterm babies at risk of chronic lung disease

D L Armstrong, J Penrice, F H Bloomfield, D B Knight, J A Dezoete, J E Harding

Department of Paediatrics, National Women's Hospital, Claude Road, Auckland, New Zealand

Correspondence to:
Correspondence to:
Professor Harding, Newborn Services, National Women's Hospital, Private Bag 92 189, Auckland, New Zealand;
j.harding{at}auckland.ac.nz

Objectives: To report 18 month outcome of a randomised trial of two courses of dexamethasone to prevent chronic lung disease of prematurity.

Study design: Babies of birth weight 1250 g or less ventilated at 7 days of age were randomised to a 42 day reducing course (long) or a 3 day pulsed (pulse) course of dexamethasone.

Growth, cardiovascular status, and respiratory and neurodevelopmental outcomes were assessed at 18 months.

Results: Seventy six babies were enrolled. Nine died and three were lost to follow up. Babies receiving the long course were weaned off oxygen more quickly than those receiving the pulse course (47% v 69% on oxygen at 28 days; p = 0.01), but there were no differences in 18 month outcomes. However, children averaged -1 SD for growth parameters, half had moderate or severe disability, and 35% and 19% respectively required oxygen at 36 weeks and discharge.

Conclusions: The dexamethasone course used did not influence long term outcome. However, entry criteria for this study selected a group of babies at high risk of poor long term outcome.

Keywords: preterm; steroids; respiratory disease; growth; development

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Onland, W., De Jaegere, A. P., Offringa, M., van Kaam, A. H. (2008). Effects of Higher Versus Lower Dexamethasone Doses on Pulmonary and Neurodevelopmental Sequelae in Preterm Infants at Risk for Chronic Lung Disease: A Meta-analysis. Pediatrics 122: 92-101 [Abstract] [Full Text]  
• Washburn, L. K., Nixon, P. A., O'Shea, T. M. (2006). Follow-up of a Randomized, Placebo-Controlled Trial of Postnatal Dexamethasone: Blood Pressure and Anthropometric Measurements at School Age. Pediatrics 118: 1592-1599 [Abstract] [Full Text]  
• Yeh, T. F., Lin, Y. J., Lin, H. C., Huang, C. C., Hsieh, W. S., Lin, C. H., Tsai, C. H. (2004). Outcomes at School Age after Postnatal Dexamethasone Therapy for Lung Disease of Prematurity. NEJM 350: 1304-1313 [Abstract] [Full Text]